Expert Insight

Content

MFN Drug Pricing: Industry Pushes Back as Biotech R&D Funding Hangs in the Balance

24 March 2026

Expert Insight

What Goes Wrong When Cell and Gene Therapy Programs Move From Clinic to Commercial

24 March 2026

Content

Middle East Airspace Closures Are Redirecting Vital Cell Therapies Away From Cancer Patients

20 March 2026

ebooks

Target Product Profile (TPP) Explained

13 March 2026

Category Guide

Drug Development Plan Explained: DPP Templates and Examples

13 March 2026

Content

Biotech CMC: Scaling Gene Therapy for Longevity

5 March 2026

Expert Insight

Most CMC Failures Are Visible Months Before They Happen

4 March 2026

Expert Insight

Why FDA’s CRL wave isn’t a CMC crisis — and what biotechs should do instead

3 March 2026

Expert Insight

Why the Best Tech Transfers Start Long Before Manufacturing

2 March 2026

Expert Insight

External Supply in a Volatile World: How to Build Pharmaceutical Supply Chain Resilience with Rx-360

1 March 2026